STOCKHOLM, May 4 (Reuters) - Icelandic generic drugs firm Actavis (ACT.IC: Quote, Profile , Research) said on Friday it had signed a deal to buy the product Floxapen from GlaxoSmithKline (GSK.L: Quote, Profile , Research) (GSK.N: Quote, Profile , Research) for the European market.
